Annual Report 2021

Share this page

Creating tomorrow’s solutions

Segment Information by Division

January 1 to December 31

 

 

 

€ million

 

Sili­cones

 

Poly­mers

 

Bio­solutions

 

Poly­silicon

 

Other

 

Consoli­dation

 

Group

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2021

 

 

 

 

 

 

 

 

 

 

 

 

 

 

External sales

 

2,599.0

 

1,653.3

 

296.4

 

1,529.8

 

129.0

 

 

6,207.5

Internal sales

 

0.1

 

20.3

 

 

 

 

-20.4

 

Total sales

 

2,599.1

 

1,673.6

 

296.4

 

1,529.8

 

129.0

 

-20.4

 

6,207.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT

 

421.0

 

198.7

 

20.7

 

528.9

 

-34.2

 

-0.8

 

1,134.3

Depreciation, amortization and (reversals of) impairments

 

131.9

 

53.9

 

17.9

 

127.8

 

72.7

 

 

404.2

EBITDA

 

552.9

 

252.6

 

38.6

 

656.7

 

38.5

 

-0.8

 

1,538.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT includes: result from investments in joint ventures and associates

 

3.9

 

 

 

 

58.5

 

 

62.4

Impairment of fixed assets

 

-0.7

 

 

 

 

 

 

-0.7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset additions1

 

143.2

 

100.1

 

33.5

 

30.6

 

36.4

 

 

343.8

Additions to financial assets

 

 

 

 

 

0.3

 

 

0.3

Asset additions

 

143.2

 

100.1

 

33.5

 

30.6

 

36.7

 

 

344.1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets (Dec. 31)

 

1,955.7

 

980.2

 

332.9

 

972.0

 

3,893.7

 

-0.2

 

8,134.3

Liabilities (Dec. 31)

 

996.1

 

538.8

 

122.1

 

583.5

 

2,793.9

 

-0.5

 

5,033.9

Net assets (Dec. 31)

 

959.6

 

441.4

 

210.8

 

388.5

 

1,099.8

 

0.3

 

3,100.4

Investments in joint ventures and associates included in net assets (Dec. 31)

 

49.3

 

 

 

 

659.6

 

 

708.9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development expenses

 

64.7

 

35.1

 

5.6

 

21.3

 

37.5

 

 

164.2

Employees (Dec. 31)

 

5,211

 

1,595

 

751

 

2,219

 

4,630

 

 

14,406

Employees (average)

 

5,157

 

1,591

 

742

 

2,195

 

4,667

 

 

14,352

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

External sales

 

2,243.8

 

1,282.1

 

246.1

 

792.2

 

128.0

 

 

4,692.2

Internal sales

 

0.2

 

16.4

 

 

 

 

-16.6

 

Total sales

 

2,244.0

 

1,298.5

 

246.1

 

792.2

 

128.0

 

-16.6

 

4,692.2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT

 

276.8

 

229.3

 

21.6

 

-147.8

 

-117.6

 

0.5

 

262.8

Depreciation, amortization and (reversals of) impairments

 

111.0

 

41.2

 

16.5

 

152.5

 

82.3

 

 

403.5

EBITDA

 

387.8

 

270.5

 

38.1

 

4.7

 

-35.3

 

0.5

 

666.3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

EBIT includes: result from investments in joint ventures and associates

 

3.4

 

 

 

 

31.5

 

 

34.9

Impairment of fixed assets

 

-0.6

 

 

 

-0.1

 

-0.3

 

 

-1.0

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Asset additions1

 

96.9

 

35.6

 

19.9

 

24.9

 

47.1

 

 

224.4

Additions to financial assets

 

 

 

 

 

0.4

 

 

0.4

Asset additions

 

96.9

 

35.6

 

19.9

 

24.9

 

47.5

 

 

224.8

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Assets (Dec. 31)

 

1,644.3

 

673.5

 

223.1

 

1,040.8

 

3,368.9

 

-0.1

 

6,950.5

Liabilities (Dec. 31)

 

955.4

 

390.7

 

109.7

 

577.9

 

3,225.0

 

 

5,258.7

Net assets (Dec. 31)

 

688.9

 

282.8

 

113.4

 

462.9

 

143.9

 

-0.1

 

1,691.8

Investments in joint ventures and associates included in net assets (Dec. 31)

 

45.0

 

 

 

 

554.5

 

 

599.5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Research and development expenses

 

60.2

 

32.2

 

5.7

 

21.3

 

37.2

 

 

156.6

Employees (Dec. 31)

 

5,076

 

1,540

 

764

 

2,180

 

4,723

 

 

14,283

Employees (average)

 

5,087

 

1,555

 

756

 

2,239

 

4,764

 

 

14,401

1

Intangible assets; property, plant and equipment; investment property; excluding right-of-use assets.

 

The segment information by division is an integral part of the Notes to the Consolidated Financial Statements. For explanations of the key indicators, see Note 23.